- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: RAD001 (Everolimus)
Total 1063 results
-
Emory UniversityNovartisTerminatedMucositis | Stage III Renal Cell Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Gastrinoma | Glucagonoma | Insulinoma | Pancreatic Polypeptide Tumor | Recurrent Islet Cell Carcinoma | Somatostatinoma | Stage IV Renal Cell Cancer | Recurrent Renal Cell Cancer | Stage IIIC Breast... and other conditionsUnited States
-
University of UtahJubilant Innovation Ltd.TerminatedCancer | Ovarian Cancer | Colon Cancer | NeuroendocrineUnited States
-
Emory UniversityNovartisCompletedHead and Neck Neoplasms | Cancer of the Head and NeckUnited States
-
Accelerated Community Oncology Research NetworkNovartis PharmaceuticalsWithdrawn
-
Novartis PharmaceuticalsCompleted
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)TerminatedLiver Metastases | Gastrinoma | Glucagonoma | Insulinoma | Pancreatic Polypeptide Tumor | Recurrent Islet Cell Carcinoma | SomatostatinomaUnited States
-
Novartis PharmaceuticalsCompletedMetastatic Breast Cancer | HER2/Neu Over-expressing Locally Advanced Breast CancerChina, United States, France, Hungary, Turkey, Japan, Germany, Singapore, Italy, Poland, Spain, United Kingdom, Thailand, Israel, Australia, Belgium, Greece, Argentina, Czech Republic, Mexico, Slovakia
-
Swiss Group for Clinical Cancer ResearchTerminated
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); NovartisActive, not recruitingRefractory Hurthle Cell Thyroid CancerUnited States
-
Washington University School of MedicineTyrogenexTerminatedAdenocarcinoma | Pancreatic NeoplasmsUnited States
-
Novartis PharmaceuticalsCompletedCarcinoid Tumor | Malignant Carcinoid SyndromeFrance, Spain, Netherlands, United States, Canada, Sweden, Italy, Australia, Germany, Greece, Belgium, Czech Republic, Slovakia, Finland, United Kingdom
-
Massachusetts General HospitalMemorial Sloan Kettering Cancer Center; Mayo Clinic; Dana-Farber Cancer Institute and other collaboratorsCompletedMultiple MyelomaUnited States
-
Dana-Farber Cancer InstituteBayer; NovartisCompletedNeuroendocrine Tumor | Carcinoid Tumor | Pancreatic Neuroendocrine TumorUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Triple-negative Breast Carcinoma | Progesterone Receptor-negativeUnited States
-
Novartis PharmaceuticalsCompletedBreast CancerUnited States, Belgium, Canada, France, Spain, Turkey, Japan, Egypt, Germany, Austria, Poland, Sweden, United Kingdom, Thailand, Hungary, Australia, Italy, Netherlands, Brazil, Hong Kong, Czech Republic, Korea, Republic of, New Zealand and more
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Brigham and Women's Hospital and other collaboratorsCompletedPancreatic Neuroendocrine TumorUnited States
-
Novartis PharmaceuticalsTerminatedIslet Cell TumorFrance, Spain, United Kingdom, Belgium, Hungary, Turkey, Canada, Argentina, Sweden, Italy, Thailand, Germany, Netherlands, Brazil, Australia, Japan, United States, Denmark, New Zealand
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Brigham and Women's HospitalCompletedNeuroendocrine Tumor | Carcinoid Tumor | Pancreatic Neuroendocrine TumorUnited States
-
Emory UniversityTerminated
-
Dana-Farber Cancer InstituteNovartis; Millennium Pharmaceuticals, Inc.TerminatedWaldenstrom's MacroglobulinemiaUnited States
-
Novartis PharmaceuticalsCompletedNon Small Cell Lung CancerFrance, Canada, United States, Russian Federation, Denmark
-
M.D. Anderson Cancer CenterNovartisCompleted
-
University of California, San FranciscoNovartisCompleted
-
Novartis PharmaceuticalsCompletedPost Menopausal Breast CancerTaiwan, Malaysia, Turkey, Australia, Korea, Republic of, Thailand, Jordan, India, Vietnam, Morocco, Tunisia, Indonesia, South Africa
-
Asan Medical CenterCompletedAdvanced Gastric CancerKorea, Republic of
-
University of California, DavisNovartisCompletedProstate CancerUnited States
-
Novartis PharmaceuticalsCompletedRenal TransplantationSwitzerland
-
Novartis PharmaceuticalsCompletedLiver Transplant RecipientBelgium, Spain, Germany, Italy, Australia, United States, Netherlands, Ireland, Sweden, Brazil, Colombia, France, Russian Federation, Argentina, Czechia, United Kingdom
-
Federico II UniversityCompletedMedullary Thyroid CancerItaly
-
Herbert HurwitzGenentech, Inc.; Novartis PharmaceuticalsCompletedColorectal AdenocarcinomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Novartis PharmaceuticalsCompletedMantle Cell Lymphoma | Gray Zone Lymphoma | Hodgkin's Disease | CD20+, B-cell Lymphomas | Non-Mantle Cell Low Grade B Cell Lymphomas (SLL/CLL) | Transformed Lymphoma/DLBCL/PMBCLUnited States
-
Yale UniversityNovartisCompletedEndometrial CancerUnited States
-
M.D. Anderson Cancer CenterNovartis; Genentech, Inc.CompletedNeuroendocrine CarcinomaUnited States
-
Milton S. Hershey Medical CenterWithdrawnMultiple MyelomaUnited States
-
University of Southern CaliforniaNovartis; Genentech, Inc.CompletedProstate CancerUnited States
-
Novartis PharmaceuticalsCompleted
-
M.D. Anderson Cancer CenterCompleted
-
SCRI Development Innovations, LLCNovartis; Genentech, Inc.TerminatedIntracranial MeningiomaUnited States
-
University of California, San FranciscoGenentech, Inc.; Novartis Pharmaceuticals; The V Foundation for Cancer ResearchTerminated
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsCompletedHEAD & NECK CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsCompletedBladder Cancer | Ureter Cancer | Renal Pelvis CancerUnited States
-
University of California, DavisNovartisCompletedMultiple Myeloma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Adult Hodgkin Lymphoma | Refractory Chronic Lymphocytic LeukemiaUnited States
-
Novartis PharmaceuticalsRecruiting
-
University of Texas Southwestern Medical CenterCompletedRecurrent Childhood EpendymomaUnited States
-
Emory UniversityNovartis; CelgeneCompletedNeuroendocrine Tumors | Solid Organ Malignancies | Adenoidcystic CarcinomaUnited States
-
SCRI Development Innovations, LLCNovartis; Genentech, Inc.CompletedKidney CancerUnited States
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI); Novartis PharmaceuticalsCompleted
-
M.D. Anderson Cancer CenterNovartisCompletedLeukemia | Myelofibrosis | Mantle Cell LymphomaUnited States
-
University of California, San FranciscoNovartisTerminatedLow Grade Glioma | World Health Organization (WHO) Grade II Astrocytomas | Oligodendrogliomas | Mixed OligoastrocytomasUnited States